Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
GE Vernova Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $250.9B | |
|---|---|---|
| Revenue (ttm) | 44B | |
| Net income (ttm) | 10.4B | |
| EPS (ttm) | $38.3 | |
| Shares out | 266.3M | |
| P/E (trailing) | 22.9x | |
| P/E (forward) | 38.2x | |
| Dividend | $2.00 (0.23%) | |
| Volume | 5,680,986 | |
| Beta | 0.97 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $33.01B | $29.65B | $33.24B | $34.94B | $38.07B | +3.6% |
| Gross profit | $4.95B | $3.46B | $4.82B | $6.09B | $7.54B | +11.1% |
| Operating income | $-692.0M | $-2.88B | $-923.0M | $471.0M | $1.39B | — |
| Net income | $-633.0M | $-2.74B | $-438.0M | $1.55B | $4.88B | — |
| EPS (diluted) | — | $-10.00 | $-1.60 | $5.58 | $17.69 | — |
| EBITDA | $484.0M | $-526.0M | $932.0M | $3.56B | $3.68B | +66.1% |
| R&D | $1.01B | $979.0M | $896.0M | $982.0M | $1.20B | +4.4% |
| SG&A | $4.82B | $5.36B | $4.85B | $4.63B | $4.95B | +0.7% |
Recent company headlines from major financial publishers.
This path preserves the operating recovery but does not assume protected pricing or an extended period of rapid growth. A sustained shortfall against the FY2027 outlook would disconfirm it.
Evidence would be continued estimate delivery, cash-backed profit and new demand visibility beyond FY2027. Weaker normalized margins or higher reinvestment would disconfirm this path.
| Ke ↓ / g → | 2.6% | 3.1% | 3.6% | 4.1% | 4.6% |
|---|---|---|---|---|---|
| 7.6% | $461 | $479 | $500 | $528 | $565 |
| 8.6% | $422 | $433 | $447 | $463 | $484 |
| 9.6% | $393 | $401 | $410 | $421 | $433 |
| 10.6% | $371 | $376 | $383 | $390 | $399 |
| 11.6% | $352 | $357 | $361 | $367 | $373 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
